Moneycontrol PRO
Upcoming Webinar:Watch a panel of experts discuss: Challenges of continuously evolving regulation for Cryptocurrency, on 7th July at 3pm. Register Now
you are here: HomeNewsBusiness

States controlling COVID-19 testing to show lower number of cases, says Thyrocare

In some states, Thyrocare has been told not to pick up samples, verbally, said A Velumani, CMD & CEO of Thyrocare Technologies

October 28, 2020 / 12:51 PM IST
A Velumani, CMD & CEO of Thyrocare Technologies (Image Source

A Velumani, CMD & CEO of Thyrocare Technologies (Image Source

Thyrocare Technologies on October 28 said that many state governments were controlling COVID-19 testing to show reduced numbers of cases due to pressure on them to show lower infections than others.

“To be very honest, government is still controlling. I am not referring to the Maharashtra government, it’s all over the country. In some states, Thyrocare has been told not to pick up samples, verbally. In some states – ‘don’t report to ICMR, reverse the data, we will tell you the cut-off, then you report’,” said A Velumani, CMD & CEO of Thyrocare Technologies, in an interview to CNBC-TV18.

Follow our LIVE Updates on the coronavirus pandemic here

“Let me tell you that because of antibody levels rising, the number of people getting admitted in hospitals is reducing, number of beds are either stagnating or coming down. So positive side is happening but the government is unnecessarily panicked to show the neighbouring state that ‘I am a better state’. They are controlling the numbers and this is unfair,” he added.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

“The Maharashtra government has cut rates of the RT-PCR COVID-19 test. The state now has the cheapest COVID-19 test in the country. “Reduction of the COVID test price in Maharashtra will not impact quality,” said Velumani.

However, he added that the COVID-19 test prices going down but volumes not rising is a concern for the industry.

“We were doing around 7,000 tests almost 60 days back per day, today only 2,500 tests and this is because Rapid Antigen Detection Test (RADT) has come in,” he said.

Source: CNBC-TV18

Follow our full COVID-19 coverage here
first published: Oct 28, 2020 12:51 pm
ISO 27001 - BSI Assurance Mark